Literature DB >> 14984622

If it is not cough, it must be dysgeusia: differing adverse effects of angiotensin-converting enzyme inhibitors in the same individual.

D Unnikrishnan1, P Murakonda, T S Dharmarajan.   

Abstract

Presented is an unusual case of a 66-year-old-resident of a long-term care facility, who manifested severe dysgeusia and impaired quality of life attributed to the angiotensin-converting enzyme (ACE) inhibitor enalapril; not realized at the time was the fact that he had an adverse reaction-cough-just weeks earlier from another ACE inhibitor in the same class, quinapril, thus illustrating different adverse effects to two antihypertensives in the same class. Cough and dysgeusia are symptoms that may be easily overlooked as side effects of medications. As polypharmacy is common in nursing home settings, health care providers need to be vigilant about adverse drug reactions which are common, but preventable and often reversible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984622     DOI: 10.1097/01.JAM.0000110651.94489.1A

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

Review 1.  Tolerability of Antihypertensive Medications in Older Adults.

Authors:  Thiruvinvamalai S Dharmarajan; Lekshmi Dharmarajan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

2.  ACE inhibitors: upper respiratory symptoms.

Authors:  Paulette Pinargote; Denisse Guillen; Juan C Guarderas
Journal:  BMJ Case Rep       Date:  2014-07-17

Review 3.  Drug-induced taste disorders.

Authors:  Richard L Doty; Muhammad Shah; Steven M Bromley
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.

Authors:  Stéphane Derruau; Jérôme Bouchet; Ali Nassif; Alexandre Baudet; Kazutoyo Yasukawa; Sandrine Lorimier; Isabelle Prêcheur; Agnès Bloch-Zupan; Bernard Pellat; Hélène Chardin; Sophie Jung
Journal:  J Clin Med       Date:  2021-02-16       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.